CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 54 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,535,077 | -15.9% | 1,000,425 | +3.7% | 0.00% | -25.0% |
Q2 2023 | $32,744,937 | -1.7% | 965,073 | +4.3% | 0.00% | 0.0% |
Q1 2023 | $33,306,986 | +84480.6% | 925,708 | +4.8% | 0.00% | -33.3% |
Q4 2022 | $39,379 | -99.8% | 883,535 | +3.6% | 0.01% | +50.0% |
Q3 2022 | $23,969,000 | +5.7% | 852,706 | +1.4% | 0.00% | +33.3% |
Q2 2022 | $22,676,000 | -22.2% | 841,124 | -1.7% | 0.00% | -25.0% |
Q1 2022 | $29,138,000 | -6.9% | 855,513 | +5.6% | 0.00% | 0.0% |
Q4 2021 | $31,314,000 | -26.8% | 810,420 | +2.3% | 0.00% | -33.3% |
Q3 2021 | $42,787,000 | +90.1% | 792,507 | +17.8% | 0.01% | +100.0% |
Q2 2021 | $22,503,000 | +209.7% | 672,948 | +90.8% | 0.00% | +200.0% |
Q1 2021 | $7,265,000 | +38.7% | 352,697 | +17.9% | 0.00% | 0.0% |
Q4 2020 | $5,239,000 | +37.1% | 299,054 | +16.1% | 0.00% | 0.0% |
Q3 2020 | $3,820,000 | +125.6% | 257,629 | +97.8% | 0.00% | – |
Q2 2020 | $1,693,000 | +884.3% | 130,237 | +25.2% | 0.00% | – |
Q1 2020 | $172,000 | -62.8% | 103,983 | -50.0% | 0.00% | – |
Q4 2019 | $462,000 | +111.0% | 207,966 | +101.5% | 0.00% | – |
Q3 2019 | $219,000 | -20.7% | 103,193 | 0.0% | 0.00% | – |
Q2 2019 | $276,000 | -48.1% | 103,193 | -4.7% | 0.00% | – |
Q1 2019 | $532,000 | – | 108,305 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |